microbiome

Developing a range of products to modify the human
microbiome and bring specific health benefits

RNS & Investor News


2016

23 December Notice of General Meeting of Warrant Holders
13 December Joint Product Agreement with multinational
01 December Exercise of Warrants and Issue of Equity
29 November Scientific and Commercial Update
03 November Presentation of research data at European Microbiome Summit
26 October Scientific and Commercial Update
20 October Optibiotix increased investment in SkinBiotix Limited
05 October Appointment of Chairman and Director for SkinBiotix Limited
28 September Appointment of Broker
23 September Exercise of Warrants and Issue of Equity
14 September Holding in Company
06 September Consumer Survey of GoFigure® products
25 August Half Yearly Report
12 August Exercise of Warrants and Issue of Equity
09 August First products in Whole Foods Market Inc
03 August Notice of Results
02 August Appointment of Director of Business Development
28 July Holding(s) in Company
26 July Slimbiome®: Successful completion of pilot launch in GoFigure® shakes and bars
14 July New patent filing: Combination ingredients to reduce cardiovascular risk factors
05 July Strategy Update
04 July Holding(s) in Company
30 June Exercise of Warrants and Issue of Equity
02 June Exercise of Warrants and Issue of Equity
19 May New patent filing: Antimicrobial Resistant (AMR) Health Care Acquired Infections
10 May Result of Annual General Meeting
20 April Exercise of Warrants and Issue of Equity
14 April Final Results for the year ended 30 November 2015
Notice of AGM
07 April Results of cholesterol human volunteer study
05 April Joint Development Agreement signed with Royal DSM
24 March Exercise of Warrants and Issue of Equity
23 March Notice of Results
22 March Second Contract signed with Instituto de Química Orgánica General, Spain
17 March Joint venture agreement with the University of Manchester
26 February Exercise of Warrants and Issue of Equity
19 February Exercise of Warrants and Issue of Equity
12 February Exercise of Warrants and Issue of Equity
05 February Placing
28 January Investor Presentation - Change of venue
26 January Exercise of Warrants and Issue of Equity
20 January Investor Presentation
19 January Professor Tim Spector joins Scientific Advisory Group
13 January Commercial Agreement signed with KSF Acquisition UK Limited

 

Presentations/Interviews

In the Media

Latest Tweets Twitter

top